Carlyle explores sale or IPO of Ortho-Clinical Diagnostics, say sources: Reuters

Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 billion, including debt, sources told Reuters.